Philip S. Low
Next Generation Targeted Therapeutics
News
2024
Secret Passageway Presentation
Philip Low to be honored by American Lung Association for cancer-fighting invention
2023
Cancer Drug Discovered in Indiana to Power Indy Novartis Plant
This Is Purdue - Full Interview with Professor Philip Low
Inside Indiana Business - Malaria
2022
Wlfi News: Purdue cancer research lab receives $8.5 million estate gift
Inside Indiana Business: Renowned Purdue Researcher Earns Another FDA Approval
U.S. Food & Drug Administration: FDA approves Pluvicto for metastatic castration-resistant prostate cancer
Purdue News: Award honors chemist for fight to beat cancer, save lives
Medical World News: Inside the Practice: Phillip Low, PhD, on the Development and Approval of Pafolacianine
2021
Purdue Research Foundation: Phil Low's seven startups and their latest news
Inside Indiana Business: FDA Approves ‘Illuminating’ Drug for Spotting Cancer
U.S. Food & Drug Administration: FDA Approves Ctyalux(pafolacianine), a New Imaging Drug to Help Identify Ovarian Cancer Lesions
Novartis: FDA grants Priority Review for investigational targeted radioligand therapy 177Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC)
Purdue News: FDA approves pioneering drug for ovarian cancer surgery
Purdue Center for Cancer Research: Member Feature
2020
New Cancer Immunotherapy https://www.purdue.edu/newsroom/releases/2020/Q4/new-cancer-immunotherapy-shows-great-promise-in-early-research.html
Inside Indiana Business https://www.insideindianabusiness.com/story/42930780/purdue-startup-secures-major-funding-round
Endpoints – MPM backs $53M round for a bold concept: Let patients make their own CAR-T in vivo: https://endpts.com/mpm-backs-53m-round-for-a-bold-concept-let-patients-make-their-own-car-t-in-vivo/
Pulmonary Fibrosis News - https://pulmonaryfibrosisnews.com/2020/11/16/new-targeted-therapies-may-ease-pulmonary-fibrosis-studies-find/
2018
Successful Purdue entrepreneurs provide targeted advice to faculty and staff entrepreneurs entering startup world
Purdue startup Endocyte sold in $2.1B deal with pharmaceutical giant Novartis
$2.1B Endocyte Deal a Record-Breaker
$1.7 million SBIR grant fast-tracks faster bone fracture healing
Indiana life sciences firms raise record $111M in venture capital in 2017
Prof. Philip S. Low gives a talk on targeted therapy at IISc
2017
Purdue-based biotech company aims to treat cancer by making cancer cells appear to glow
Desi scientist in US discovers molecule that illuminates cancer cells
2016
Purdue research may expand engineered T-cell cancer treatment
Purdue Centre for Drug Discovery Targeting Tumors with Engineered T-Cell Therapy
Research could expand engineered T-cell cancer treatment
2015
Not-for-profit startup aims to evaluate Purdue drug compounds before clinical trials
2014
On Target Laboratories begins Phase 2 clinical trials for its cancer imaging agent
New technology could 'light up' cancer cells and improve surgical outcomes
Purdue University discovery leads to Endocyte drug
2013
2011
Glow-In-the-Dark Cells Help Find Ovarian Cancer
Videos